Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Supercritical Fluid Techniques for Nanoparticle Preparation

Posted on By

SOP for Supercritical Fluid Techniques for Nanoparticle Preparation

Standard Operating Procedure for Supercritical Fluid Techniques for Nanoparticle Preparation

1) Purpose

This SOP describes the procedure for using supercritical fluid techniques to prepare nanoparticles. Supercritical fluid methods offer controlled particle size and high purity in nanoparticle production.

2) Scope

This SOP applies to personnel responsible for using supercritical fluids, such as CO2, to prepare nanoparticles for pharmaceutical and industrial applications.

3) Responsibilities

  • Operators: Responsible for setting up and operating the supercritical fluid system to produce nanoparticles.
  • QA: Ensures the nanoparticles meet particle size, purity, and quality requirements.
See also  SOP for Use of Polymeric Micelles in Nanoparticle Formulations

4) Procedure

4.1 Setup of Supercritical Fluid Equipment

4.1.1 Equipment Calibration

  • 4.1.1.1 Calibrate the supercritical fluid system according to manufacturer instructions.

4.2 Supercritical Fluid Process

4.2.1 Introduction of Supercritical CO2

  • 4.2.1.1 Introduce the material (polymer or drug solution) into the supercritical fluid system under controlled temperature and pressure conditions.
  • 4.2.1.2 Gradually increase the pressure of the CO2 to reach supercritical conditions.

4.2.2 Nanoparticle Formation

  • 4.2.2.1 Use the supercritical fluid to dissolve and then rapidly precipitate the material, forming nanoparticles.

4.3 Particle Size and Purity Testing

4.3.1 Dynamic Light Scattering (DLS)

  • 4.3.1.1 Measure the particle size using DLS or a similar method to ensure nanoparticles are within the desired size range.
See also  SOP for Solvent Evaporation Method for Nanoparticles

4.3.2 Purity Testing

  • 4.3.2.1 Test the purity of the nanoparticles to ensure they are free from residual
solvents and impurities.

4.4 Storage

4.4.1 Storage Conditions

  • 4.4.1.1 Store the nanoparticles in sterile, sealed containers at room temperature or 4°C.

5) Abbreviations, if any

  • DLS: Dynamic Light Scattering

6) Documents, if any

  • Supercritical Fluid Nanoparticle Logbook

7) References, if any

  • Guidelines for using supercritical fluids in nanoparticle production

8) SOP Version

Version 1.0

Annexure

Supercritical Fluid Nanoparticle Logbook Template

Date Batch Number Material Used Particle Size Purity Operator Initials QA Initials
DD/MM/YYYY Batch Number Material Name Size in nm Pass/Fail Operator Name QA Name
           
See also  SOP for Preparation of Nanoparticles for Sublingual Administration
Nanoparticle Formulation Tags:Nanoparticle biomedical applications SOP, Nanoparticle clinical trial SOP, Nanoparticle encapsulation SOP, Nanoparticle formulation SOP, Nanoparticle handling SOP, Nanoparticle preparation procedure, Nanoparticle production SOP, Nanoparticle quality control SOP, Nanoparticle size optimization SOP, Nanoparticle SOP, Nanoparticle stability testing SOP, Nanoparticle standard operating procedures, Nanoparticle sterilization SOP, Nanoparticle storage SOP, Nanoparticle surface modification SOP, Nanoparticle synthesis SOP, Nanoparticle toxicology SOP, SOP for nanomaterials, SOP for nanoparticle characterization, SOP for nanoparticle drug delivery, SOP for nanoparticle gene delivery, SOP for nanoparticle regulatory compliance, SOP for nanoparticle safety, SOP for nanoparticle scaling, SOP for targeted drug delivery nanoparticles

Post navigation

Previous Post: SOP for Preparing Lyophilized Formulations for Oral Administration
Next Post: SOP for Use of Polyols in Lyophilized Formulations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version